Konovo Launches, Uniting Three Market Research Firms for Enhanced Insights

Konovo Announces Its Official Launch: A New Era in Medical Market Research On May 12, 2025, Konovo, a technology-driven healthcare intelligence company based in Watertown, Massachusetts, officially announced its formation. The company's mission is to streamline and integrate the market research ecosystem, enabling researchers, suppliers, and data sources to achieve faster, better, and more interconnected insights. This new entity emerged from the merging of three highly respected brands—InCrowd, Survey Healthcare Global (SHG), and GlocalMind—each known for their expertise in different aspects of market research. One of the primary challenges that Konovo aims to address is the fragmentation and isolation prevalent in traditional market research. These issues often lead to slow research progress, reduced efficiency, and compromised data quality. By leveraging advanced AI technologies and deep industry knowledge, Konovo is poised to revolutionize the field. Their AI-native platform enhances the speed and depth of research through features like AI-assisted survey design, which significantly boosts response rates and participant engagement. The platform's interoperability allows seamless integration of real-time agile research methods with detailed long-term studies, offering clients a versatile array of research tools. Konovo CEO Tal Rosenberg highlighted the importance of speed and collaboration in market research: "Current complex systems and fragmented processes hinder our ability to deliver timely, actionable insights. Our clients and partners need comprehensive and operational data to refine their strategies and make informed decisions. With our substantial investments in intelligent platforms, expert teams, and diverse research populations, we are confident in creating valuable, measurable experiences for everyone." One of the standout features of Konovo's platform is its extensive database of healthcare professionals and social groups, including physicians, key opinion leaders (KOLs), patients, and other stakeholders. This rich resource pool, combined with connections to multiple health data networks, ensures that clients receive high-quality, comprehensive, and actionable market intelligence. The platform also includes robust AI-driven fraud detection and sample validation mechanisms, ensuring the reliability of data even in highly specialized fields. Looking ahead, Konovo has an ambitious product roadmap. In 2025, they plan to launch automated report generation and longitudinal client profiling across studies. These enhancements will further expand the capabilities and utility of the platform, providing clients with more detailed and integrated insights. The company's website, konovo.com, has been updated to reflect the new brand identity, including a new logo and visual recognition system. Konovo will also be showcasing its innovations at the BHBIA annual conference in the UK, scheduled for May 12-13, 2025. Industry Reaction and Company Background The formation of Konovo has been met with widespread applause from industry insiders. Experts view this merger not just as a consolidation of successful companies but as a significant leap forward in the integration of AI technology with medical market research. They predict that Konovo could reshape the landscape of the industry, becoming a pivotal bridge connecting researchers, data sources, and audiences. Konovo is an investment portfolio company of Frazier Healthcare Partners, a renowned private equity firm with a strong track record of supporting healthcare innovations. This backing provides Konovo with the financial muscle to expand globally and invest heavily in research and development. The company currently operates in 13 countries across the Americas, Europe, and Asia, maintaining a vast network of stakeholders and data sources. Through its smart platform, broad influence, and specialized services, Konovo aims to simplify research processes, bridge fragmented insights, and enhance access to hard-to-reach healthcare professionals. This unique combination of resources and technology positions Konovo to deliver deeper and more practical market intelligence to leading market research firms, consulting companies, pharmaceutical brands, and healthcare organizations worldwide. In sum, Konovo's official launch marks a significant milestone in the medical market research sector. By combining the strengths of InCrowd, SHG, and GlocalMind, and harnessing cutting-edge AI technologies, Konovo is set to transform how researchers, suppliers, and data sources collaborate and derive insights. With a robust product roadmap and strong market presence, Konovo is expected to lead the industry into a new era of intelligent and efficient market research. Evaluation by Industry Insiders and Company Profile Industry experts see Konovo's establishment as a game-changer in medical market research. The integration of AI with market research methodologies not only streamlines processes but also enhances data quality and reliability. As a portfolio company of Frazier Healthcare Partners, Konovo benefits from a solid financial foundation and strategic support, enabling it to scale rapidly and innovate continuously. The company's global reach and comprehensive database of healthcare stakeholders make it a formidable force in the market, capable of providing nuanced and actionable insights that can significantly impact decision-making in the healthcare industry. The upcoming BHBIA conference will be a key platform for Konovo to demonstrate its capabilities and cement its position as a leader in the field.